{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T09:36:44Z","timestamp":1785317804317,"version":"3.55.0"},"reference-count":33,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2021,6,29]],"date-time":"2021-06-29T00:00:00Z","timestamp":1624924800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"name":"Theranica Bio-Electronics Ltd"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,4,8]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Objective<\/jats:title>\n                  <jats:p>There is an unmet need for new, efficacious, well-tolerated, acute treatments for migraine in adolescents. Remote electrical neuromodulation (REN) is a novel, nonpharmacological treatment that provides significant symptom relief with good tolerability. The current post hoc analysis compared the efficacy of REN to that of standard-care medications for the acute treatment of migraine in adolescents.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Design<\/jats:title>\n                  <jats:p>Within-participant post hoc analysis of data from a clinical trial.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Setting<\/jats:title>\n                  <jats:p>Data from a clinical trial.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Subjects<\/jats:title>\n                  <jats:p>Data from 35 adolescent participants were analyzed.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>Efficacy was compared between a run-in phase, in which attacks were treated with standard-care medications (triptans or over-the-counter medications), and an intervention phase, in which attacks were treated with REN. Efficacy was compared within participants through the use of McNemar\u2019s test at four endpoints (2 hours after treatment): single-treatment pain freedom and pain relief, and consistency of pain freedom and pain relief (defined as response in at least 50% of the available first four treatments).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>At 2 hours after treatment, pain freedom was achieved by 37.1% of the participants with REN, vs 8.6% of the participants with medications (P\u2009=\u20090.004). Pain relief was achieved by 71.4% with REN, vs 57.1% with medications (P\u2009=\u20090.225). Consistency of pain freedom was achieved by 40% with REN, vs 8.6% with medications (P\u2009&amp;lt;\u20090.001). Consistency of pain relief was achieved by 80.0% with REN, vs 57.2% with medications (P\u2009=\u20090.033).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>Our results suggest that REN may have higher efficacy than certain standard-care medications for the acute treatment of migraine in adolescents. A larger-scale, blinded comparative-effectiveness and tolerability study is needed.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/pm\/pnab197","type":"journal-article","created":{"date-parts":[[2021,6,27]],"date-time":"2021-06-27T11:07:46Z","timestamp":1624792066000},"page":"815-820","source":"Crossref","is-referenced-by-count":18,"title":["Comparison of Remote Electrical Neuromodulation and Standard-Care Medications for Acute Treatment of Migraine in Adolescents: A Post Hoc Analysis"],"prefix":"10.1093","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1598-7536","authenticated-orcid":false,"given":"Andrew D","family":"Hershey","sequence":"first","affiliation":[{"name":"Division of Neurology, Cincinnati Children\u2019s Hospital Medical Center, Cincinnati, Ohio, USA"},{"name":"Department of Pediatrics, University of Cincinnati, College of Medicine Cincinnati, Cincinnati, Ohio, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samantha","family":"Irwin","sequence":"additional","affiliation":[{"name":"Child & Adolescent Headache Program, Department of Neurology, University of California, San Francisco (UCSF), San Francisco, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liron","family":"Rabany","sequence":"additional","affiliation":[{"name":"Theranica Bio-Electronics LTD, Netanya, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaron","family":"Gruper","sequence":"additional","affiliation":[{"name":"Theranica Bio-Electronics LTD, Netanya, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alon","family":"Ironi","sequence":"additional","affiliation":[{"name":"Theranica Bio-Electronics LTD, Netanya, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dagan","family":"Harris","sequence":"additional","affiliation":[{"name":"Theranica Bio-Electronics LTD, Netanya, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roni","family":"Sharon","sequence":"additional","affiliation":[{"name":"Headache & Facial Pain, Sheba Medical Center, Ramat, Gan, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"McVige","sequence":"additional","affiliation":[{"name":"Concussion Clinic, Dent Neurologic Institute, Amherst, New York, USA"},{"name":"State University at Buffalo Medical School, Buffalo, New York, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2021,6,29]]},"reference":[{"issue":"6","key":"2022040813461753900_pnab197-B1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11916-013-0341-z","article-title":"Epidemiology of migraine and headache in children and adolescents","volume":"17","author":"W\u00f6ber-Bing\u00f6l","year":"2013","journal-title":"Curr Pain Headache Rep"},{"issue":"9","key":"2022040813461753900_pnab197-B2","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1177\/0333102409355601","article-title":"Migraine prevalence by age and sex in the United States: A life-span study","volume":"30","author":"Victor","year":"2010","journal-title":"Cephalalgia"},{"issue":"18","key":"2022040813461753900_pnab197-B3","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1212\/WNL.0b013e318271f812","article-title":"Migraine and migraine subtypes in preadolescent children: Association with school performance","volume":"79","author":"Arruda","year":"2012","journal-title":"Neurology"},{"issue":"1","key":"2022040813461753900_pnab197-B4","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1111\/j.1526-4610.1993.hed3301029.x","article-title":"Impact of migraine in the United States: Data from the National Health Interview Survey","volume":"33","author":"Stang","year":"1993","journal-title":"Headache"},{"issue":"1 Pt 1","key":"2022040813461753900_pnab197-B5","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1542\/peds.112.1.e1","article-title":"Quality of life in childhood migraines: Clinical impact and comparison to other chronic illnesses","volume":"112","author":"Powers","year":"2003","journal-title":"Pediatrics"},{"issue":"4","key":"2022040813461753900_pnab197-B6","first-page":"CD005220","article-title":"Drugs for the acute treatment of migraine in children and adolescents","volume":"4","author":"Richer","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"issue":"3","key":"2022040813461753900_pnab197-B7","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/S1474-4422(10)70005-3","article-title":"Current practice and future directions in the prevention and acute management of migraine","volume":"9","author":"Goadsby","year":"2010","journal-title":"Lancet Neurol"},{"issue":"10","key":"2022040813461753900_pnab197-B8","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1038\/nrneurol.2016.124","article-title":"Medication-overuse headache: Risk factors, pathophysiology and management","volume":"12","author":"Diener","year":"2016","journal-title":"Nat Rev Neurol"},{"issue":"4","key":"2022040813461753900_pnab197-B9","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1007\/s11916-009-0048-3","article-title":"Overuse of acute migraine medications and migraine chronification","volume":"13","author":"Bigal","year":"2009","journal-title":"Curr Pain Headache Rep"},{"key":"2022040813461753900_pnab197-B10","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.pediatrneurol.2016.01.022","article-title":"Predictors of triptan response in pediatric migraine","volume":"58","author":"Johnson","year":"2016","journal-title":"Pediatr Neurol"},{"issue":"4","key":"2022040813461753900_pnab197-B11","doi-asserted-by":"crossref","first-page":"151","DOI":"10.2217\/bem-2019-0024","article-title":"Peripheral neuromodulation for the treatment of migraine and headache: Recent advances","volume":"2","author":"Hou","year":"2019","journal-title":"Bioelectron Med"},{"issue":"2","key":"2022040813461753900_pnab197-B12","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1097\/SPC.0000000000000126","article-title":"Conditioned pain modulation","volume":"9","author":"Nir","year":"2015","journal-title":"Curr Opin Support Palliat Care"},{"issue":"5","key":"2022040813461753900_pnab197-B13","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.ejpain.2010.10.001","article-title":"A psychophysical study of endogenous analgesia: The role of the conditioning pain in the induction and magnitude of conditioned pain modulation","volume":"15","author":"Nirl","year":"2011","journal-title":"Eur J Pain"},{"issue":"6","key":"2022040813461753900_pnab197-B14","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1016\/j.pain.2012.02.021","article-title":"Conditioned pain modulation predicts duloxetine efficacy in painful diabetic neuropathy","volume":"153","author":"Yarnitsky","year":"2012","journal-title":"Pain"},{"issue":"2","key":"2022040813461753900_pnab197-B15","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1111\/head.14042","article-title":"Remote electrical neuromodulation for acute treatment of migraine in adolescents","volume":"61","author":"Hershey","year":"2021","journal-title":"Headache"},{"issue":"13","key":"2022040813461753900_pnab197-B16","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1212\/WNL.0000000000003760","article-title":"Nonpainful remote electrical stimulation alleviates episodic migraine pain","volume":"88","author":"Yarnitsky","year":"2017","journal-title":"Neurology"},{"issue":"8","key":"2022040813461753900_pnab197-B17","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1111\/head.13551","article-title":"Remote electrical neuromodulation (REN) relieves acute migraine: A randomized, double-blind, placebo-controlled, multicenter trial","volume":"59","author":"Yarnitsky","year":"2019","journal-title":"Headache"},{"issue":"12","key":"2022040813461753900_pnab197-B18","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1080\/17434440.2019.1695599","article-title":"Device profile of the NerivioTM for acute migraine treatment: Overview of its efficacy and safety","volume":"16","author":"Rapoport","year":"2019","journal-title":"Expert Rev Med Devices"},{"key":"2022040813461753900_pnab197-B19","doi-asserted-by":"crossref","first-page":"226","DOI":"10.3389\/fneur.2020.00226","article-title":"Incorporating remote electrical neuromodulation (REN) into usual care reduces acute migraine medication use: An open-label extension study","volume":"11","author":"Marmura","year":"2020","journal-title":"Front Neurol"},{"issue":"1","key":"2022040813461753900_pnab197-B20","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1186\/s10194-019-1033-9","article-title":"Remote electrical neuromodulation (REN) in the acute treatment of migraine: A comparison with usual care and acute migraine medications","volume":"20","author":"Rapoport","year":"2019","journal-title":"J Headache Pain"},{"issue":"12","key":"2022040813461753900_pnab197-B21","doi-asserted-by":"crossref","first-page":"3522","DOI":"10.1093\/pm\/pnaa299","article-title":"Real-world experience with remote electrical neuromodulation in the acute treatment of migraine","volume":"21","author":"Tepper","year":"2020","journal-title":"Pain Med"},{"issue":"1","key":"2022040813461753900_pnab197-B22","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1186\/s10194-020-01204-4","article-title":"Neuromodulation techniques for acute and preventive migraine treatment: A systematic review and meta-analysis of randomized controlled trials","volume":"21","author":"Moisset","year":"2020","journal-title":"J Headache Pain"},{"key":"2022040813461753900_pnab197-B23","author":"Tassorelli","year":"2018"},{"issue":"2","key":"2022040813461753900_pnab197-B24","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1177\/0333102417737765","article-title":"Randomized, double-blind, placebo-controlled, parallel-group, multi-center study of the safety and efficacy of ADAM zolmitriptan for the acute treatment of migraine","volume":"38","author":"Spierings","year":"2018","journal-title":"Cephalalgia"},{"issue":"5","key":"2022040813461753900_pnab197-B25","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1177\/0333102410388435","article-title":"BI 44370 TA, an oral CGRP antagonist for the treatment of acute migraine attacks: Results from a phase II study","volume":"31","author":"Diener","year":"2011","journal-title":"Cephalalgia"},{"issue":"6","key":"2022040813461753900_pnab197-B26","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1111\/j.1526-4610.2006.00443.x","article-title":"Pain characteristics of the acute migraine attack","volume":"46","author":"Kelman","year":"2006","journal-title":"Headache"},{"issue":"10","key":"2022040813461753900_pnab197-B27","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1177\/0333102412451358","article-title":"Efficacy and tolerability of rizatriptan in pediatric migraineurs: Results from a randomized, double-blind, placebo-controlled trial using a novel adaptive enrichment design","volume":"32","author":"Ho","year":"2012","journal-title":"Cephalalgia"},{"issue":"1","key":"2022040813461753900_pnab197-B28","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1046\/j.1526-4610.2002.02013.x","article-title":"Rizatriptan 5 mg for the acute treatment of migraine in adolescents: A randomized, double-blind, placebo-controlled study","volume":"42","author":"Winner","year":"2002","journal-title":"Headache"},{"issue":"8","key":"2022040813461753900_pnab197-B29","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1046\/j.1526-4610.2002.02180.x","article-title":"Children\u2019s ibuprofen suspension for the acute treatment of pediatric migraine","volume":"42","author":"Lewis","year":"2002","journal-title":"Headache"},{"issue":"9","key":"2022040813461753900_pnab197-B30","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1111\/j.1526-4610.2011.01965.x","article-title":"Long-term evaluation of sumatriptan and naproxen sodium for the acute treatment of migraine in adolescents","volume":"51","author":"McDonald","year":"2011","journal-title":"Headache"},{"issue":"4","key":"2022040813461753900_pnab197-B31","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1111\/head.12555","article-title":"Consistency of response to sumatriptan\/naproxen sodium in a randomized placebo-controlled, cross-over study for the acute treatment of migraine in adolescence","volume":"55","author":"Winner","year":"2015","journal-title":"Headache"},{"issue":"5","key":"2022040813461753900_pnab197-B32","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1111\/j.1468-2982.2003.00690.x","article-title":"Double-blind clinical trials of oral triptans vs other classes of acute migraine medication\u2014a review","volume":"24","author":"Lipton","year":"2004","journal-title":"Cephalalgia"},{"issue":"21","key":"2022040813461753900_pnab197-B33","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1001\/jamainternmed.2013.10391","article-title":"Differential effectiveness of placebo treatments: A systematic review of migraine prophylaxis","volume":"173","author":"Meissner","year":"2013","journal-title":"JAMA Intern Med"}],"container-title":["Pain Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/painmedicine\/advance-article-pdf\/doi\/10.1093\/pm\/pnab197\/39543243\/pnab197.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/painmedicine\/article-pdf\/23\/4\/815\/43335680\/pnab197.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/painmedicine\/article-pdf\/23\/4\/815\/43335680\/pnab197.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,8]],"date-time":"2022-04-08T13:58:51Z","timestamp":1649426331000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/painmedicine\/article\/23\/4\/815\/6311270"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,29]]},"references-count":33,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2021,6,29]]},"published-print":{"date-parts":[[2022,4,8]]}},"URL":"https:\/\/doi.org\/10.1093\/pm\/pnab197","relation":{},"ISSN":["1526-2375","1526-4637"],"issn-type":[{"value":"1526-2375","type":"print"},{"value":"1526-4637","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2022,4,1]]},"published":{"date-parts":[[2021,6,29]]}}}